التفاصيل البيبلوغرافية
العنوان: |
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial |
المؤلفون: |
Motzer, Robert J., Russo, Paul, Grünwald, Viktor, Tomita, Yoshihiko, Zurawski, Bogdan, Parikh, Omi, Buti, Sebastiano, Barthélémy, Philippe, Goh, Jeffrey C., Ye, Dingwei, Lingua, Alejo, Lattouf, Jean-Baptiste, Albigès, Laurence, George, Saby, Shuch, Brian, Sosman, Jeffrey, Staehler, Michael, Vázquez Estévez, Sergio, Simsek, Burcin, Spiridigliozzi, Julia, Chudnovsky, Aleksander, Bex, Axel |
المساهمون: |
Bristol-Myers Squibb |
المصدر: |
Targeted Oncology ; volume 18, issue 5, page 639-641 ; ISSN 1776-2596 1776-260X |
بيانات النشر: |
Springer Science and Business Media LLC |
سنة النشر: |
2023 |
مصطلحات موضوعية: |
Pharmacology (medical), Cancer Research, Oncology |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1007/s11523-023-00987-1 |
DOI: |
10.1007/s11523-023-00987-1.pdf |
DOI: |
10.1007/s11523-023-00987-1/fulltext.html |
الإتاحة: |
https://doi.org/10.1007/s11523-023-00987-1Test |
حقوق: |
https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test |
رقم الانضمام: |
edsbas.A7A12E77 |
قاعدة البيانات: |
BASE |